American Picture House Corp 10-K

ITEM 5. MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. Market Information Our common shares are qualified for quotation on the OTC Markets - OTC:QB under the symbol “APHP”. On March 25, 2026, the highest trade was for $0.3400 and the low was $0.0105. Any over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not necessarily represent actual transactions. Quarterly period High Low Fiscal year ended December 31, 2025: $ 0.3400 $ 0.0105 First Quarter $ 0.3400 $ 0.2150 Second Quarter $ 0.3079 $ 0.1211 Third Quarter $ 0.2499 $ 0.1000 Fourth Quarter $ 0.2620 $ 0.0150 Fiscal year ended December 31, 2024: $ 0.3500 $ 0.1450 First Quarter $ 0.3300 $ 0.2201 Second Quarter $ 0.3500 $ 0.1500 Third Quarter $ 0.3500 $ 0.1450 Fourth Quarter $ 0.3400 $ 0.2010 Holders As of March 25, 2026, we had 336 shareholders of record of common shares per our transfer agent’s shareholder list with others in street name. Dividends The Company has not declared any cash dividends since inception and does not anticipate paying any cash dividends in the foreseeable future. The payment of cash dividends is within the discretion of the Board of Directors and will depend on the Company’s earnings, capital requirements, financial condition, and other relevant factors. There are no restrictions that currently limit the Company’s ability to pay cash, or other, dividends on its Common Shares other than those generally imposed by applicable state law. It is the present intention of management to utilize all available funds for the growth of the Company’s business. 19 Equity Compensation Plan Information On December 13, 2023, the Board of Directors approved the American Picture House Corporation 2023 Directors, Employees and Advisors Stock Incentive and Compensation Plan (the “Plan”). The Plan is administered by the Board of Directors and provides for grants of options to purchase shares of the Company’s authorized but unissued common stock, which options may be either incentive stock options or nonqualified stock options. As originally adopted, the maximum number of shares of common stock that could be issued pursuant to awards granted under the Plan was 10,000,000 shares. In November 2024, the Company’s stockholders approved an increase in the number of shares issuable under the Plan, subject to an overall limitation equal to twenty percent (20%) of the Company’s issued and outstanding common shares at the time of grant. If any outstanding options expire, terminate, or are forfeited for any reason, the shares subject to such options that are not exercised may again become available for grant under the Plan. During 2024, the Company granted an aggregate of 10,653,438 stock options under the Plan, consisting of (i) 5,083,471 options granted on February 8, 2024, of which 500,000 were later forfeited, and (ii) 5,569,967 options granted on November 21, 2024 following stockholder approval of the increase in the number of shares issuable under the Plan. During 2025, the Company did not grant any additional options, and an aggregate of 6,319,967 stock options were forfeited. As of December 31, 2025, 3,833,471 options remained outstanding with an exercise price of $0.0125 per share. Subsequent to year end, on January 15, 2026, the Company granted an additional 500,000 stock options under the Plan. Common and Preferred Shares Our authorized capital shares consist of 1,000,000,000 common shares and 1,000,000 preferred shares, par value $0.0001 per share, of which 100,000 preferred shares have been designated as Series A Convertible Preferred Stock (“Series A preferred shares” herein). As of March 25, 2026, there were 113,599,325 common shares issued and outstanding and 3,839 Series A preferred shares issued and outstanding, of which 100,000 preferred shares have been designated as Series A Convertible Preferred Stock (“Series A preferred shares” herein). Issuer Purchases of Equity Securities. During the quarter ended December 31, 2025, the Company did not repurchase any shares of its common stock or other equity securities. Unregistered Securities Sales Disclosure Recent Sales of Unregistered Securities. During the fiscal year ended December 31, 2025, the Company did not sell any equity securities that were not registered under the Securities Act of 1933, as amended. ITEM 6. [RESERVED]